TITLE

Drug Co. Feels Ills of Market, Pulls $2.2B TL

AUTHOR(S)
Kellerhals, Richard
PUB. DATE
March 2011
SOURCE
High Yield Report;3/28/2011, Vol. 22 Issue 13, p9
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the cancellation of a 2.2 billion U.S. dollar term loan B for marketing and research provider Quintiles because of unfavorable global credit market conditions.
ACCESSION #
59683225

 

Related Articles

  • Quintiles Markets $1.975B TLB. Sibayan, Karen // High Yield Report;12/17/2012, p19 

    The article reports on the term loan B worth 1.975 billion dollars being marketed by Quintiles Transnational Corp. in December 2012.

  • Quantiles Markets TLB. Sibayan, Karen // High Yield Report;12/17/2012, p20 

    The article reports on the term loan B worth 1.975 billion dollars being marketed by Quintiles Transnational Corp. in December 2012.

  • Quintiles Gets Add-On Loan, Increases Revolver. Bisbey, Allison // High Yield Report;10/22/2012, p6 

    The article highlights the 175 million U.S. dollars add-on term loan obtained by Quintiles Transnational Corp. and the company's decision to upsize its revolving line of credit to 300 million U.S. dollars to help fund a distribution to the firms' private equity sponsors.

  • Quintiles Puts $2B CF Back on Table. Iyer, Gayatri // High Yield Report;5/16/2011, Vol. 22 Issue 20, p13 

    The article reports on the 2.23-billion U.S. dollar credit facility of Quintiles Transnational, consisting of a term loan B and a five-year revolver.

  • JPM Sets Price on Quintiles $2B TL. Iyer, Gayatri // High Yield Report;5/16/2011, Vol. 22 Issue 20, p17 

    The article reports that JPMorgan has set pricing on the term loan B of Quintiles Transnational.

  • Three Cos. Ready $985M in HY Deals. Sheahan, Matthew // High Yield Report;12/7/2009, Vol. 20 Issue 49, p9 

    This article reports on the addition by three companies of 985 million U.S. dollars to the high yield bond pipeline. 400 million U.S. dollars in senior notes due 2014 are being offered by Quintiles Transnational in a bid to pay a dividend to private equity firms TPG Capital and Bain Capital....

  • Quintiles provides cure for Green Park HQ.  // Estates Gazette;6/19/2010, Issue 1024, p47 

    The article reports that the pharmaceutical firm Quintiles has made an offer to lease a purpose-built building at Green Park in Reading, England owned by PRUPIM.

  • Quintiles Consulting.  // BioPharm International;Dec2001, Vol. 14 Issue 12, p72 

    Focuses on the corporate capabilities of Quintiles Consulting in Rockville, Maryland. Company description; Services offered; Management schemes.

  • Building a transnational company. Mangelsdorf, Martha E. // Inc.;Mar93, Vol. 15 Issue 3, p92 

    Profiles Quintiles Transnational Corp., Morrisville, N.C., whose chief executive Dennis Gillings uses faceless communication as a big part of the business. The company administers and analyzes drug-testing studies that pharmaceutical companies prepare for government agencies and has grown to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics